Direct Funding

Action to Cure Kidney Cancer has directly funded kidney cancer research since 2006 and has provided eleven grants to seven researchers totaling $382,282.50. The following details specific information about each grant by year, identifying the researcher, his or her institution, the purpose of the grant and the amount paid. The grants cover a broad spectrum of research from attempting to develop an early screening test for kidney cancer to working to find treatments for the different types of kidney cancer.

Kidney Cancer Research Projects

Therapies for Papillary Renal Cell Carcinoma

2014-2016 — $60,000
Marston Linehan
National Cancer Institute

Project: Non-clear cell research, specifically therapies for papillary renal cell carcinoma.

Role of Gene SETD2 in Development of Kidney Cancer

2012 — $45,000
Eric Jonasch
MD Anderson Cancer Center

Project: Examine consequences of the loss of the gene SETD2 and the formation of kidney cancer.

Kidney Cancer Clinical Work and Research Studies

2011 — $10,000
Janice Dutcher
St. Lukes Roosevelt Hospital

Project: Support her kidney cancer clinical and research work at Roosevelt Hospital in New York City.

Radiological Treatment for Metastic Kidney Cancer

2010 — $30,000
Denise Chan
University of California, San Francisco

Project: Study the efficacy of radiological treatment for metastic kidney cancer.

Prevention of Glucose Uptake in VHL-Mutated Cells

2009 — $45,000
Amato Giaccia
Stanford University

Project: Support the study of a protein that prevents glucose uptake in VHL-mutated cells and thereby, via synthetic lethality, destroys the kidney cancer cells.

Identification of Human Endogenous Retrovirus (HERV)

2009, 2008, 2007, 2006 — $35,600, 55,600, 20,000, 35,000 respectively, for a total of $146,200
Richard Childs
National Institutes of Health

Project: Support the identification of a human endogenous retrovirus (HERV) that is selectively expressed on 80 percent of renal cell carcinoma cells.

Analysis of Polymearse Chain Reaction (PCR)

2006 — $44,782.50
Paul Cairns
Fox Chase Cancer Center

Project: Purchase a Polymearse Chain Reaction (PCR) machine to analyze DNA in order to develop a urine test that would detect early stage kidney cancer.